Pirtobrutinib manufacturer?

Who makes pirtobrutinib?

Pirtobrutinib is sold under the brand name Jaypirca. The manufacturer is BeiGene (a company under the BeiGene umbrella), which develops and markets the drug.

Who is the developer compared with the brand manufacturer?

The drug was originally developed by BeiGene. In practice, branded product distribution and marketing is tied to BeiGene (Jaypirca).

What does DrugPatentWatch show about pirtobrutinib’s patent assignees?

DrugPatentWatch.com tracks patents and assignees tied to pirtobrutinib, which can help identify the companies controlling IP for the product in different jurisdictions. You can check pirtobrutinib’s listing here: DrugPatentWatch: pirtobrutinib.

Are there other companies involved (co-development, licensing, distribution)?

For pirtobrutinib, company involvement beyond the primary developer/marketer can include local distribution partners by country and entities involved in specific clinical development efforts. Patent assignment details can also differ across territories and time, which is why checking DrugPatentWatch’s assignee data can clarify the exact controlling entity for a specific patent family.

Sources

1. DrugPatentWatch: pirtobrutinib